The US Court of Appeals for the Federal Circuit remanded the case to the Patent Trial and Appeal Board to consider patent validity.

The agreement will enable Beijing-based RocGene to distribute its qPCR systems, reagents, and consumables in South Korea and to explore additional market strategies.

The company's full-year 2025 revenues rose 6 percent year over year, with a 4 percent decline in diagnostics for the year.

The agency cleared lab-based and point-of-care infectious disease and clinical chemistry tests as well as software for digital pathology.

The company's full-year 2025 revenues rose 6 percent year over year, with a 4 percent decline in diagnostics for the year.

The company's full-year 2025 revenues rose 6 percent year over year, with a 4 percent decline in diagnostics for the year.

NEW YORK — Scientific instrument maker Horiba said on Wednesday that it has received CE IVDR certification for its Yumizen H500 CRP benchtop hematology analyzer. The point-of-care system performs ...

Along with decreased headwinds, Abbott's diagnostics business is expected to get a boost with its $23 billion acquisition of Exact Sciences, which is anticipated to close in the second quarter. In a ...

The firm's benchtop TruVerus system can now run a total of 26 FDA-cleared assays in three modalities from a single blood collection tube.

The autoimmune diagnostic company expects its new assay to be available by the end of this year or in early 2027.